Chemoinformaics analysis of 6,7-DIHYDROXYCOUMARIN-6-GLUCOSIDE
| Molecular Weight | 340.284 | nRot | 3 |
| Heavy Atom Molecular Weight | 324.156 | nRig | 18 |
| Exact Molecular Weight | 340.079 | nRing | 3 |
| Solubility: LogS | -1.985 | nHRing | 2 |
| Solubility: LogP | -1.068 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 11 |
| nHA | 9 | APOL | 42.9367 |
| nHD | 5 | BPOL | 22.1273 |
| QED | 0.429 |
| Synth | 3.732 |
| Natural Product Likeliness | 2.146 |
| NR-PPAR-gamma | 0.031 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.491 |
| HIA | 0.829 |
| CACO-2 | -5.95 |
| MDCK | 0.000186059 |
| BBB | 0.765 |
| PPB | 0.561006 |
| VDSS | 0.626 |
| FU | 0.454914 |
| CYP1A2-inh | 0.057 |
| CYP1A2-sub | 0.074 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.315 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.25 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.027 |
| CL | 4.015 |
| T12 | 0.592 |
| hERG | 0.048 |
| Ames | 0.293 |
| ROA | 0.058 |
| SkinSen | 0.05 |
| Carcinogencity | 0.738 |
| EI | 0.012 |
| Respiratory | 0.029 |
| NR-Aromatase | 0.074 |
| Antiviral | Yes |
| Prediction | 0.589187 |